Advertisement LAB Research Canadian Site Obtains GLP Certification - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

LAB Research Canadian Site Obtains GLP Certification

LAB Research, a Canada-based global non-clinical contract research organization (CRO), has obtained good laboratory practices (GLP) recognition from the Standards Council of Canada (SCC).

LAB Research supports the development of its customers’ products from three facilities located in Canada, Denmark and Hungary.

GLP compliance of the Canadian laboratory site has been recognized by formal document issued in May 2010 under the SCC GLP Compliance Program based upon an inspection and study audits conducted in November 2009 in the areas of analytical and clinical chemistry, ADME, bioanalytical, immunology, safety pharmacology, toxicokinetics and toxicity testing of pharmaceuticals.

Luc Mainville, president and CEO of LAB Research, said: “The confirmation of our GLP compliance status reaffirms the Canadian site’s GLP compliance to Organisation for Economic Co-operation and Development (OECD)-GLP standards following the successful audit by the German authorities several years ago.

“This successful OECD-GLP inspection of our Canadian laboratory also follows successful GLP audits of each of our Danish and Hungarian laboratories. We are pleased to offer the greatest level of quality and GLP compliant environment to our clients around the world.

“These positive GLP audits will help us broaden our clientele following our service and site expansions that positioned LRI as a high quality, global full service non-clinical contract research organization.”